K M C Speciality Hospitals (India) growth over the years

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr3 yr
Revenue+13.7%+20.0%
EBITDA+14.7%+26.8%
Net Income+13.8%+33.5%
EPS (adj.)+13.8%+33.5%
Free Cash Flow—+14.5%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KMCSHIL₹149.36

K M C Speciality Hospitals (India) Limited

· Pharma & Health
₹ CrorePeersDRAGARWQKOVAILOTUSEYEGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMEDMcap ₹2,439 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue+13.7+20.0
EBITDA+14.7+26.8
Net Income+13.8+33.5
EPS (adj.)+13.8+33.5
Free Cash Flow—+14.5
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.